Cornell Pochily Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,046
| Closed | -$202K | – | 180 |
|
|
2024
Q3 | $202K | Sell |
2,046
-115
| -5% | -$11.4K | 0.07% | 175 |
|
|
2024
Q2 | $200K | Sell |
2,161
-20
| -0.9% | -$1.85K | 0.08% | 166 |
|
|
2024
Q1 | $207K | Sell |
2,181
-439
| -17% | -$41.6K | 0.08% | 167 |
|
|
2023
Q4 | $234K | Buy |
+2,620
| New | +$234K | 0.1% | 159 |
|
|
2023
Q3 | – | Sell |
-2,590
| Closed | -$215K | – | 174 |
|
|
2023
Q2 | $215K | Buy |
+2,590
| New | +$215K | 0.09% | 159 |
|
|
2023
Q1 | – | Sell |
-2,562
| Closed | -$213K | – | 170 |
|
|
2022
Q4 | $213K | Hold |
2,562
| – | – | 0.1% | 165 |
|
|
2022
Q3 | $203K | Buy |
+2,562
| New | +$203K | 0.09% | 161 |
|
|
2021
Q4 | – | Sell |
-2,292
| Closed | -$288K | – | 168 |
|
|
2021
Q3 | $288K | Buy |
+2,292
| New | +$288K | 0.12% | 141 |
|
|
2021
Q1 | – | Sell |
-2,244
| Closed | -$316K | – | 154 |
|
|
2020
Q4 | $316K | Buy |
+2,244
| New | +$316K | 0.15% | 122 |
|
|
2020
Q3 | – | Sell |
-2,543
| Closed | -$285K | – | 147 |
|
|
2020
Q2 | $285K | Buy |
+2,543
| New | +$285K | 0.18% | 108 |
|
|
2020
Q1 | – | Sell |
-2,517
| Closed | -$239K | – | 139 |
|
|
2019
Q4 | $239K | Sell |
2,517
-140
| -5% | -$13.3K | 0.14% | 125 |
|
|
2019
Q3 | $203K | Hold |
2,657
| – | – | 0.13% | 129 |
|
|
2019
Q2 | $233 | Buy |
2,657
+50
| +2% | +$4 | 0.06% | 138 |
|
|
2019
Q1 | $236K | Buy |
+2,607
| New | +$236K | 0.16% | 116 |
|